Promoting vascular repair in the retina: Can stem/progenitor cells help?

Thao Le Phuong Trinh, Sergio Li Calzi, Lynn C. Shaw, Mervin C. Yoder, Maria B. Grant

Research output: Contribution to journalReview article

9 Scopus citations


Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina.

Original languageEnglish (US)
Pages (from-to)113-122
Number of pages10
JournalEye and Brain
StatePublished - May 26 2016


  • Cd34 cells
  • Endothelial colony-forming cells
  • Endothelial progenitor cells
  • Oxygen-induced retinopathy
  • Retinopathy of prematurity
  • Rop therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Promoting vascular repair in the retina: Can stem/progenitor cells help?'. Together they form a unique fingerprint.

  • Cite this